ENDOCRINOLOGY

Page 1

FRCPath Part 2 Surgical Course Endocrine Pathology Dr Preetha Chengot


Case 1

Case No 1


Case 1

Clinical History F,19y. Adrenal mass. 30mm diameter yellow nodule.


Case 1

Histopathology Images







Case 1

What is your diagnosis?


Case 1

Diagnosis Pheochromocytoma


• MEN 2 • Von Hippel Lindau • Neurofibromatosis type 1 • Malignant phaeo more common in pts with SDHB mutation


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 1


Case 2

Case No 2


Case 2

Clinical History Female, 59y. Thyroid nodule.


Case 2

Histopathology Images





Case 2

What is your diagnosis?


Case 2

Diagnosis Medullary carcinoma


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 2


Case 3

Case No 3


Case 3

Clinical History Female, 43y.Neck mass.


Case 3

Histopathology Images






Case 3

What is your diagnosis?


Case 3

Diagnosis Metastatic dedifferentiated Hurthle cell carcinoma.


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 3


Case 4

Case No 4


Case 4

Clinical History 55 yr male. Large thyroid mass.


Case 4

Histopathology Images




Case 4

What is your diagnosis?


Case 4

Diagnosis Sarcomatous transformation in papillary thyroid carcinoma


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 4


Case 5

Case No 5


Case 5

Clinical History Female, 52y. Radiolucent lesion T3.


Case 5

Histopathology Images






Case 5

What is your diagnosis?


Case 5

Diagnosis Metastatic adrenal cortical carcinoma


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 5


Case 6

Case No 6


Case 6

Clinical History Female 42 y. Left level 4 lymph node.





Case 6

Histopathology Images








Case 6

What is your diagnosis?


Case 6

Diagnosis Metastatic diffuse sclerosing variant of papillary carcinoma


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 6


Case 7

Case No 7


Case 7

Clinical History Female, 53y. Right adrenal gland.






Case 7

What is your diagnosis?


Case 7

Diagnosis Collision tumour – adrenal cortical adenoma and ganglioneuroma


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 7


Case 8

Case No 8


Case 8

Clinical History Female, 52y. Left thyroid lobectomy.


Case 8

Histopathology Images




Case 8

What is your diagnosis?


Case 8

Diagnosis Widely invasive follicular carcinoma.


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 8


Case 9

Case No 9


Case 9

Clinical History Male, 54y. Right adrenal gland.


Case 9

Histopathology Images




Case 9

What is your diagnosis?


Case 9

Diagnosis Composite pheochromocytoma-ganglioneuroma.


• MEN 2a Von Recklinghausen’s disease Neurofibromatosis Can be bilateral phaeo with ganglioneuroma, neuroblastoma or ganglioneuroblastoma. Bilateral phaeo- MPNST


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 9


Case 10

Case No 10


Case 10

Clinical History Male, 47y. Right adrenalectomy.


Case 10

Histopathology Images



Case 10

What is your diagnosis?


Case 10

Diagnosis Conn’s tumour


• Carney’s complex • MEN 1 • McCune- Albright syndrome • Familial hyperaldosteronism types 1 & 2 - congenital adrenal hyperplasia.


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 10


Case 11

Case No 11


Case 11

Clinical History Female, 60y.Left adrenalectomy


Case 11

Histopathology Images


Case 11

What is your diagnosis?


Case 11

Diagnosis Metastatic colorectal adenocarcinoma


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 11


Case 12

Case No 12


Case 12

Clinical History Female, 32y, Right thyroid lobectomy





Case 12

What is your diagnosis?


Case 12

Diagnosis Parathyroid carcinoma


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 12


• Hyperparathyroidism- jaw tumour syndrome • HRPT2 gene mutation • Fibroosseous lesions of jaws • Kidney cysts, hamartomas, carcinomas. • Late adolescence • Higher incidence of PTH carcinoma than MEN1 and 2a


Case 13

Case No 13


Case 13

Clinical History Male, 59y, Left thyroid lobectomy


Case 13

Histopathology Images




Case 13

What is your diagnosis?


Case 13

Diagnosis Papillary carcinoma with tall cell areas.


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 13


Case 14

Case No 14


Case 14

Clinical History Female, 52y. Large thyroid mass.


Case 14

Histopathology Images



Case 14

What is your diagnosis?


Case 14

Diagnosis Poorly differentiated (insular) carcinoma arising in papillary thyroid carcinoma


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 14


Case 15

Case No 15


Case 15

Clinical History Female, 59y. Adrenal mass.


Case 15

Histopathology Images




Case 15

What is your diagnosis?


Case 15

Diagnosis Metastatic malignant melanoma


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 15


Case 16 • Adrenal mass F 65









Diagnosis • Adrenal cortical carcinoma


• Li- Fraumeni Syndrome • Beckwith- Wiedemann syndrome • Weiss criteria • Reticulin algorithm


Marking Scheme 3.5

3.0

2.5

2.0 1.5 1.0

Case 15


Case 17 • Recurrent hyperparathyroidism 42 M




Diagnosis • Parathyromatosis


Criteria used for NIFTP diagnosis Major criteria

Minor criteria

Exclusion criteria

1. Encapsulation or clear demarcation 2. Follicular growth pattern (<1% papillae) 3. Nuclear Features of PTC (Score 2 or 3): Enlargement/crowding/ overlapping Elongation Irregular contours Grooves Pseudoinclusions Chromatin clearing

1. Dark/hypereosinophilic colloid 2. Irregularly-shaped follicles 3. Intratumoral acellular, eosinophilic fibrosis 4. “Sprinkling” sign (multifocal involvement within a single nodule) 5. Follicles cleft from stroma 6. Multinucleated giant cells within follicles

1. “True” papillae >1% 2. Psammoma bodies 3. Infiltrative border (capsular or lymphovascular invasion) 4. Tumor necrosis 5. High mitotic activity (>3/10 HPFs) 6. Cell/morphologic characteristics of other variants of PTC



Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.